Aurélie BOUZELMAT

En résumé

Entreprises

• Hôpital Robert Debré - AP-HP - Éudiant

  maintenant Dans le laboratoire de diagnostisque de génétique moléculaire de l'hôpital Robert Debré. Paris.
  
  
  I developed a Methyl-Sensitive PCR of the human 14q32 intergenic differentially methylated region. My mission was to create a diagnosis method to identify epigenetic dysregulations leading to a Prader-Willi like syndrome. The technique was validated and is now available for the laboratory.

• McGill Université - Étudiant

  2010 - maintenant Dans le laboratoire du Prof. Moshe Szyf, Departement de Pharmacologie Therapeutiques de la Faculté de Médicine, McGill Université. Montréal (Canada):
  
  Set up a pool of epigenetic biomarkers for liver cancer. I analyzed patients’ tumour and normal samples with HRM (High Resolution Melting analysis) in order to identify precise probes differentially methylated in cancer and normal samples. This pool could be used as an early diagnostic. I validated my results with pyrosequencing and built controls with Whole Genome Amplification (WGA) and in-vitro methylation.
  Patent on the process of being filed.

Formations

• Mc Gill University (Montréal (Québec))

  Montréal (Québec) 2009 - 2011 Master of Science applied in biotechnoloy

• Université Paris 6 Pierre Et Marie Curie Biologie moléculaire et cellulaire

  Paris 2008 - 2009 Génétique Moléculaire
  
  Master 1

• Université Paris 6 Pierre Et Marie Curie UPMC

  Paris 2002 - 2006 avec mention

Réseau

• Alexandre PELOUZE

• Bonnefoit ALINE

• Caroline ZEILAS

• Claire ROUX

• Driss CHADER

• Fairouz BOUZELMAT

• Louise VANHELLE

• Morgane DELMAS

• Paul CHAMPENOIS